InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Bate Kenneth, Director. Insider active across 3 companies, notably Epizyme, Inc.. Aggregated, 12 disclosures have been logged. History available since 11 June 2021. The latest transaction was filed on 5 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bate Kenneth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
5,470 shares@ US$9.454.9% of flowCommon StockSEC:0001628280-25-050668:0
10,000 shares@ US$16.4616.3% of flowCommon StockSEC:0001210238-25-000005:0
715 shares0Common StockSEC:0001628280-25-032863:0
6,000 shares@ US$111.0687.8% of flowCommon StockSEC:0001628280-25-009076:0
714 shares0Common StockSEC:0000950170-24-078754:0
10,000 shares@ US$9.4512.2% of flowCommon StockSEC:0000899243-24-000245:0
1,198 shares0Common StockSEC:0000899243-23-016056:0
375 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-23-002195:0
8,060 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028858:0
8,994 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028858:1
8,994 shares0Common Stock, par value $0.0001SEC:0000899243-22-018843:0
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023878:0
12 of 12 declarations
About Bate Kenneth
BATE KENNETH is an Administrateur and has 12 filings in total. In the 12 sampled filings, sell transactions total EUR 5,209, the filings run from 2021-06-15 to 2025-11-07, and the main filings concern Madrigal Pharmaceuticals, INC. and Aveo Pharmaceuticals, INC.
